Market Size of Global Homocysteine Testing Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 8.00 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Homocysteine Testing Market Analysis
The Homocysteine Testing Market is projected to register a CAGR of 8% during the forecast period (2022-2027).
Amidst the COVID-19, the homocysteine testing market is expected to grow during the growth the market owing to the increase of homocysteine testing to predict the severity of the COVID-19 infections. For instance, in 2021 the article titled 'homocysteine assessment to predict outcomes of hospitalized COVID-19 patients: a multicenter study on 313 COVID-19 patients' mentioned that homocysteine has recently been proposed as a potential predictive biomarker for COVID-19 infection severity. The report also mentioned that the optimal cut-off for homocysteine as predictive of in-hospital mortality was estimated to be 41% and 83 % of sensitivity and specificity, respectively. Such increasing advantages provided by the homocyetine testing during the pandemic period is expected to boost the growth of the market.
The factors such as increasing geriatric population coupled with the increasing alcohol consumption and other life style related disorders are expected to drive the growth of the market. For instance the article titled 'Hospice in the Santa Clara Area : how Folic acid may impact aging and Dimentia' published in 2022 mentioned that nearlt 25% of people over the age of 65 do not get enough vitain B12 which is very important for brain and neurological sytem function. Similarly , the article titled 'Serum Folate deficiency in older people may be associated with heightened dementia and deat risk' published in 2022, published that 1 in 5 older adults estimated to be folate deficient. Furthermore, According to the World Health Organization (WHO) report in 2021 the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2030. As the elderly population is expected to grow in the coming years, the market may also witness growth as the elderly are to be continously monitored. Such increase in the folic acid deficiency in the geriatric population is expected to drive the demand for homoscyteine testing inorder to get effective treatment , thereby contributing to the growth of the market.
Homocysteine Testing Industry Segmentation
As per the scope of the report, Homocysteine is a building block of protein i.e., a common amino acid that is produced in the blood. High levels of homocysteine can lead to the early development of heart-related disorders, renal disease and can cause deficiency of vitamins B6, vitamin B12 and folate. The Homocysteine Testing Market is segmented by Type (Folic Acid, Pyridoxine, Cobalamin), Form (Tablet, Syrup, Others), Distribution Channel (Hospital Pharmacies, Drug Stores and Others) and Geography (North America, Europe, Asia-pacific, middle east, Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
By Type | |
Folic Acid | |
Pyridoxine | |
Cobalamin |
By Form | |
Tablet | |
Syrup | |
Others |
By Distribution Channel | |
Hospital Pharmacies | |
Drug Stores | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Homocysteine Testing Market Size Summary
The Homocysteine Testing Market is anticipated to experience significant growth over the forecast period, driven by various factors including the increasing prevalence of lifestyle-related disorders and the aging population. The market's expansion is further supported by the heightened demand for homocysteine testing during the COVID-19 pandemic, where it was identified as a potential biomarker for predicting the severity of infections. The growing geriatric population, coupled with issues such as folic acid deficiency, is expected to bolster the demand for homocysteine testing, as these factors are linked to neurological health and the risk of cardiovascular events. The market is characterized by a competitive landscape with several key players, including major pharmaceutical and diagnostic companies, which are contributing to the market's development through innovative testing solutions and strategic expansions.
Folic acid is projected to maintain a dominant position in the market due to its critical role in mitigating homocysteine levels, thereby reducing the risk of heart attacks and strokes. The United States is expected to lead the global market, supported by its advanced healthcare infrastructure, high compliance rates for blood testing, and a significant population seeking treatment. The presence of major market players in this region, along with factors such as alcohol consumption and lifestyle changes, is likely to drive market growth. The market remains fragmented, with numerous companies competing for market share, and ongoing developments in laboratory testing capabilities are expected to further enhance the market's growth prospects.
Global Homocysteine Testing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing geriatric population
-
1.2.2 Increasing life style habits leading to risks of heart and renal diseases
-
-
1.3 Market Restraints
-
1.3.1 Lack of awareness regarding the deficiency of vitamins in blood
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size
-
2.1 By Type
-
2.1.1 Folic Acid
-
2.1.2 Pyridoxine
-
2.1.3 Cobalamin
-
-
2.2 By Form
-
2.2.1 Tablet
-
2.2.2 Syrup
-
2.2.3 Others
-
-
2.3 By Distribution Channel
-
2.3.1 Hospital Pharmacies
-
2.3.2 Drug Stores
-
2.3.3 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Homocysteine Testing Market Size FAQs
What is the current Global Homocysteine Testing Market size?
The Global Homocysteine Testing Market is projected to register a CAGR of 8% during the forecast period (2024-2029)
Who are the key players in Global Homocysteine Testing Market?
ARUP Laboratories, Sekisui Diagnostics , Machaon Diagnostics , Bio-Rad Laboratories and F. Hoffmann La Roche are the major companies operating in the Global Homocysteine Testing Market.